Rucaparib
Rucaparib comes in 3 pill versions in our database, in 3 strengths, from 1 manufacturer. Check the imprint to tell them apart.
Rucaparib pill images
200 mg 1 pill
250 mg 1 pill
300 mg 1 pill
What is Rucaparib used for?
Rucaparib is used for ovarian neoplasms.
- Medicine type
- Poly(adp-ribose) polymerase inhibitor
Official uses from the US prescribing label
Maintenance Treatment of BRCA-mutated Recurrent Ovarian Cancer
RUBRACA is indicated for the maintenance treatment of adult patients with a deleterious BRCAmutation (germline and/or somatic)-associated recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.
BRCA-mutated Metastatic Castration-Resistant Prostate Cancer
RUBRACA is indicated for the treatment of adult patients with a deleterious BRCAmutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor-directed therapy. Select patients for therapy based on an FDA-approved companion diagnostic for RUBRACA.
From the FDA-approved label on DailyMed (published Jan 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.